Synthetic Biology – News and Features

Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene’s function.

NETSENSOR is a research consortium in the field of synthetic biology. Its purpose is to develop a system that detects a particular type of malfunction in the cell.

In one of the first potential applications of synthetic biology, researchers are engineering viruses to attack and destroy the surface "biofilms" that harbor harmful bacteria in the body.

Expands access to industry-leading gene synthesis offering.

Open Biosystems will distribute Codon Devices’ gene synthesis offering in North America.

The research collaboration provides Servier with access to deCODE’s expertise in de novo protein crystal structure determination.

Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology.

The Institute will no longer be organized under the two research divisions TIGR and TCAG, but will now encompass an administrative team and several research groups.

The collaboration creates a protocol that uses IG’s Pichia yeast expression system with Coda translational protein expression.

Invitrogen will invest in Blue Heron in exchange for worldwide rights to distribute Blue Heron's custom gene synthesis services.